학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 1,999건 | 목록 1~20
Editorial & Opinion
Fernando F; Imperial College Healthcare NHS Trust Hammersmith Hospital London UK.; Centre For Haematology, Department of Immunology and Inflammation, Hammersmith Campus Imperial College London London UK.; Wasko C; Centre For Haematology, Department of Immunology and Inflammation, Hammersmith Campus Imperial College London London UK.; Johns B; Centre For Haematology, Department of Immunology and Inflammation, Hammersmith Campus Imperial College London London UK.; Claudiani S; Imperial College Healthcare NHS Trust Hammersmith Hospital London UK.; Centre For Haematology, Department of Immunology and Inflammation, Hammersmith Campus Imperial College London London UK.; Khan A; Imperial College Healthcare NHS Trust Hammersmith Hospital London UK.; Innes AJ; Imperial College Healthcare NHS Trust Hammersmith Hospital London UK.; Centre For Haematology, Department of Immunology and Inflammation, Hammersmith Campus Imperial College London London UK.; Milojkovic D; Imperial College Healthcare NHS Trust Hammersmith Hospital London UK.; Centre For Haematology, Department of Immunology and Inflammation, Hammersmith Campus Imperial College London London UK.; Apperley JF; Imperial College Healthcare NHS Trust Hammersmith Hospital London UK.; Centre For Haematology, Department of Immunology and Inflammation, Hammersmith Campus Imperial College London London UK.
Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101761942 Publication Model: eCollection Cited Medium: Internet ISSN: 2688-6146 (Electronic) Linking ISSN: 26886146 NLM ISO Abbreviation: EJHaem Subsets: PubMed not MEDLINE
Academic Journal
Lauseker M; Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie (IBE), Medizinische Fakultät, Ludwig-Maximilians-Universität München, Munich, Germany. lauseker@ibe.med.uni-muenchen.de.; Sacha T; Jagiellonian University Medical College, Department of Hematology, Krakow, Poland.; Klamova H; Institute of Hematology and Blood Transfusion, Prague, Czech Republic.; Yakoleva J; RM Gorbacheva Research Institute, Pavlov University, Saint Petersburg, Russia.; Lomaia E; Research Department of Immuno-Oncology, Almazov National Medical Research Centre, Saint Petersburg, Russian Federation.; Milojkovic D; Hammersmith Hospital, Imperial College NHS Trust, London, UK.; Fabisch C; Klinik für Innere Medizin II, Universitätsklinikum Jena, Jena, Germany.; Nicolini FE; Centre Léon Bérard, Hématology Department, Lyon, France.; CRCL INSERM U1052, Lyon, France.; Olsson-Stromberg U; University Hospital Uppsala, Department of Hematology, Uppsala, Sweden.; Zackova D; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic.; Lewandowski K; Department of Hematology & Bone Marrow Transplantation, Poznań University of Medical Sciences, Poznań, Poland.; Ernst P; Klinik für Innere Medizin II, Universitätsklinikum Jena, Jena, Germany.; Castagnetti F; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy.; Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy.; Hirschbühl K; Hematology and Oncology, Faculty of Medicine, University of Augsburg, Augsburg, Germany.; Zupan I; Department of Haematology, University Medical Centre Ljubljana, Ljubljana, Slovenia.; Medical Faculty, University of Ljubljana, Ljubljana, Slovenia.; Voskanyan A; Hematology Center after Prof. R. Yeolyan, Yerevan, Armenia.; Gołos A; Hematooncology Department, Copernicus Memorial Hospital, Lodz, Poland.; Frietsch JJ; Medizinischen Klinik und Poliklinik II, Uniklinikum Würzburg, Würzburg, Germany.; Gil J; Oncology Centre of the Podkarpackie Province, Department of Hematooncology, Brzozow, Poland.; Faber E; Department of Hemato-Oncology, University Hospital Olomouc, Faculty of Medicine and Dentistry, Palacky University in Olomouc, Olomouc, Czech Republic.; Krause SW; Uniklinik Erlangen, Medizinische Klinik 5, Erlangen, Germany.; Parry A; Centre Hospitalier Annecy Genevois, Annecy, France.; Saussele S; III. Med. Klinik, Med. Fakultät Mannheim, Universität Heidelberg, Mannheim, Germany.; Heibl S; Abteilung für Innere Medizin IV, Klinikum Wels-Grieskirchen, Wels, Austria.; Franke GN; University of Leipzig Medical Center, Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Diseases, Leipzig, Germany.; Casado LF; Servicio de Hematología, Hospital General Universitario de Toledo, Toledo, Spain.; Paczkowska E; Department of General Pathology, Pomeranian Medical University in Szczecin, Szczecin, Poland.; Hebart H; Zentrum für Innere Medizin, Hämatologie/Onkologie, Stauferklinikum Schwäbisch-Gmünd, Mutlangen, Germany.; Eder M; Klinik für Hämatologie, Hämostaseologie, Onkologie und Stammzelltransplantation, Medizinische Hochschule Hannover, Hannover, Germany.; Anhut P; Onkologische Schwerpunktpraxis Anhut, Kronach, Germany.; Trautmann-Grill K; Medizinische Klinik I, Universitätsklinikum Carl Gustav Carus, TU Dresden, Dresden, Germany.; Szczepanek E; Jagiellonian University Medical College, Department of Hematology, Krakow, Poland.; Südhoff T; Klinikum Passau, Klinik für Onkologie, Hämatologie und Palliativmedizin, Passau, Germany.; Patkowska E; Hematology Department, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.; Kiani A; Medizinische Klinik IV, Klinikum Bayreuth GmbH, Bayreuth, and Comprehensive Cancer Center Erlangen-EMN, Bayreuth, Germany.; Ernst T; Klinik für Innere Medizin II, Universitätsklinikum Jena, Jena, Germany.; Apperley J; Centre for Haematology, Imperial College NHS Trust, London, UK.; Mayer J; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic.; Hochhaus A; Klinik für Innere Medizin II, Universitätsklinikum Jena, Jena, Germany.; Pfirrmann M; Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie (IBE), Medizinische Fakultät, Ludwig-Maximilians-Universität München, Munich, Germany.; Brioli A; Klinik für Innere Medizin II, Universitätsklinikum Jena, Jena, Germany. brioli.annamaria@mh-hannover.de.; Klinik für Hämatologie, Hämostaseologie, Onkologie und Stammzelltransplantation, Medizinische Hochschule Hannover, Hannover, Germany. brioli.annamaria@mh-hannover.de.; Klinik und Poliklinik für Innere Medizin C, Hämatologie und Onkologie, Universitätsmedizin Greifswald, Greifswald, Germany. brioli.annamaria@mh-hannover.de.
Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE
Academic Journal
Eur J Haematol
Claudiani, S, Janssen, J J W M, Byrne, J, Smith, G, Blijlevens, N, Raghavan, M, Smith, M, Clark, R E, Mclain-Smith, S, Carter, A M, Milojkovic, D & Apperley, J F 2022, 'A retrospective observational research study to describe the real-world use of bosutinib in patients with chronic myeloid leukemia in the United Kingdom and the Netherlands', European Journal of Haematology, vol. 109, no. 1, pp. 90-99. https://doi.org/10.1111/ejh.13775
European Journal of Haematology, 109, 1, pp. 90-99
Academic Journal
Nat Commun
Nature Communications, Vol 14, Iss 1, Pp 1-21 (2023)
Fang, Z, Corbizi Fattori, G, McKerrell, T, Boucher, R H, Jackson, A, Fletcher, R S, Forte, D, Martin, J-E, Fox, S, Roberts, J, Glover, R, Harris, E, Bridges, H R, Grassi, L, Rodriguez-Meira, A, Mead, A J, Knapper, S, Ewing, J, Butt, N M, Jain, M, Francis, S, Clark, F J, Coppell, J, McMullin, M F, Wadelin, F, Narayanan, S, Milojkovic, D, Drummond, M W, Sekhar, M, ElDaly, H, Hirst, J, Paramor, M, Baxter, E J, Godfrey, A L, Harrison, C N & Méndez-Ferrer, S 2023, 'Tamoxifen for the treatment of myeloproliferative neoplasms: A Phase II clinical trial and exploratory analysis', Nature Communications, vol. 14, 7725. https://doi.org/10.1038/s41467-023-43175-5
Academic Journal
Hazell L; Imperial College Clinical Trials Unit, Imperial College London, London, UK.; Pillay C; Department of Immunology and Inflammation, Imperial College London, London, UK.; Imperial College Healthcare NHS Trust, London, UK.; Cornelius V; Imperial College Clinical Trials Unit, Imperial College London, London, UK.; Phillips R; Imperial College Clinical Trials Unit, Imperial College London, London, UK.; Charania A; Department of Immunology and Inflammation, Imperial College London, London, UK.; Imperial College Healthcare NHS Trust, London, UK.; Wason J; Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.; Cherlin S; Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.; Savic S; Immunology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.; University of Leeds, Leeds, West Yorkshire, UK.; Whittington A; Infectious Diseases and Acute Medicine, Northwick Park Hospital, Harrow, London, UK.; Neelakantan P; Haemato-Oncology, Royal Berkshire NHS Foundation Trust, Reading, UK.; Collini P; Department of Infectious Diseases, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.; Cook L; Department of Immunology and Inflammation, Imperial College London, London, UK.; Imperial College Healthcare NHS Trust, London, UK.; Willicome M; Department of Immunology and Inflammation, Imperial College London, London, UK.; Imperial College Healthcare NHS Trust, London, UK.; Milojkovic D; Department of Immunology and Inflammation, Imperial College London, London, UK.; Imperial College Healthcare NHS Trust, London, UK.; Kon OM; Respiratory Medicine, Imperial College Healthcare NHS Trust, London, London, UK.; National Heart and Lung Institute, Imperial College London, London, London, UK.; Youngstein T; Imperial College Healthcare NHS Trust, London, UK.; National Heart and Lung Institute, Imperial College London, London, London, UK.; Innes A; Department of Immunology and Inflammation, Imperial College London, London, UK.; Imperial College Healthcare NHS Trust, London, UK.; Thursz M; Imperial College Healthcare NHS Trust, London, UK.; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.; Cooke GS; Imperial College Healthcare NHS Trust, London, UK.; Department of Infectious Diseases, Imperial College London, London, UK.; Vergis N; Department of Immunology and Inflammation, Imperial College London, London, UK.; Imperial College Healthcare NHS Trust, London, UK.; Cooper N; Department of Immunology and Inflammation, Imperial College London, London, UK n.cooper@imperial.ac.uk.; Imperial College Healthcare NHS Trust, London, UK.
Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-6055 (Electronic) Linking ISSN: 20446055 NLM ISO Abbreviation: BMJ Open Subsets: MEDLINE
Academic Journal
Publisher: Karger Country of Publication: Switzerland NLM ID: 0135054 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1423-0232 (Electronic) Linking ISSN: 00302414 NLM ISO Abbreviation: Oncology Subsets: MEDLINE
Academic Journal
IEEE Transactions on Electromagnetic Compatibility IEEE Trans. Electromagn. Compat. Electromagnetic Compatibility, IEEE Transactions on. 49(3):722-726 Aug, 2007
Academic Journal
Silvestri, G, Trotta, R, Stramucci, L, Ellis, J J, Harb, J G, Neviani, P, Wang, S, Eisfeld, A-K, Walker, C J, Zhang, B, Srutova, K, Gambacorti-Passerini, C, Pineda, G, Jamieson, C H M, Stagno, F, Vigneri, P, Nteliopoulos, G, May, P C, Reid, A G, Garzon, R, Roy, D-C, Moutuou, M M, Guimond, M, Hokland, P, Deininger, M W, Fitzgerald, G, Harman, C, Dazzi, F, Milojkovic, D, Apperley, J F, Marcucci, G, Qi, J, Polakova, K M, Zou, Y, Fan, X, Baer, M R, Calabretta, B & Perrotti, D 2020, 'Persistence of Drug-Resistant Leukemic Stem Cells and Impaired NK Cell Immunity in CML Patients Depend on MIR300 Antiproliferative and PP2A-Activating Functions', Blood cancer discovery, vol. 1, no. 1, pp. 48-67. https://doi.org/10.1158/0008-5472.BCD-19-0039
Conference
2012 20th Telecommunications Forum (TELFOR) Telecommunications Forum (TELFOR), 2012 20th. :1005-1011 Nov, 2012
Conference
2007 8th International Conference on Telecommunications in Modern Satellite, Cable and Broadcasting Services Telecommunications in Modern Satellite, Cable and Broadcasting Services, 2007. TELSIKS 2007. 8th International Conference on. :494-497 Sep, 2007
검색 결과 제한하기
제한된 항목
[검색어] Milojkovic, D
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어